Use of a gamma-secretase inhibitor for treating cancer

Details for Australian Patent Application No. 2009203776 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Packman, Kathryn E.; Luistro III, Leopoldo Ladores; Boylan, John Frederick

Agent Davies Collison Cave

Pub. Number AU-A-2009203776

PCT Pub. Number WO2009/087130

Priority 61/020,447 11.01.08 US

Filing date 5 January 2009

Wipo publication date 16 July 2009

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/7068 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/087130 Priority application(s): WO2009/087130

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009203785-Molecular in vitro diagnosis of breast cancer

2009203774-Signature method and device